Fatigue News and Research

RSS

An exercise pill for heart failure patients

According to latest research, scientists at the Ottawa University, Canada have come up with a pill that can mimic the effects of regular exercise. This could be significantly beneficial to heart failure patients. The study was published in the journal Nature.

10 Aug 2017

Immunotherapy shows promise in treatment of Type 1 diabetes

Around 1.25 million Americans are living with type 1 diabetes and 40,000 new cases are detected each year. In this condition body’s own immune system attacks and damages the insulin-producing β-cells inside the pancreas leading to impaired glucose metabolism in the body. There is no other treatment for this condition than regular painful insulin injections to maintain the normal insulin levels in the body. Type 1 diabetes is currently considered to be incurable.

10 Aug 2017

Early detection, treatment of frailty may help elderly people live healthier lives

Age-related frailty may be a treatable and preventable health problem, just like obesity, diabetes, and cardiovascular disease, highlights a review in Frontiers in Physiology.

9 Aug 2017

Increase in reported cases of Cyclospora infections compared to last year, CDC reports

The Centers for Disease Control and Prevention (CDC) has released a Health Alert Network (HAN) Health Advisory on 7th August 2017, Monday, in order to alert the health care facilities and the public health department on the increase in the reported cases of cyclosporiasis.

9 Aug 2017

Shortage of Hepatitis B vaccine - prioritization of vaccinations announced in UK

According to a recent announcement made by Public Health England, there is a global shortage of vaccines used against hepatitis B infection. This announcement is followed up by a “prioritisation guidance” which means that persons who are at greatest risk of getting hepatitis B are to be vaccinated on priority if they have not received the vaccine before.

7 Aug 2017

FDA approves new treatment for all HCV genotypes 1-6

The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients with moderate to severe kidney disease and those who are on dialysis.

3 Aug 2017

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

The U.S. Food and Drug Administration (FDA) yesterday approved Vyxeos - a fixed dose combination chemotherapy for the treatment of adults with two types of acute myeloid leukemia (AML). The types of AML that would be treated with Vyxeos include newly diagnosed therapy-related AML (t-AML) and AML with myelodysplasia-related changes (AML-MRC). Vyxeos is a fixed-combination of the chemotherapy drugs daunorubicin and cytarabine.

3 Aug 2017

FDA approves new combo drug Mavyret for adults with Hepatitis C infection

Yesterday the U.S. Food and Drug Administration gave its approval to Mavyret (glecaprevir and pibrentasvir) for the treatment of adults with chronic hepatitis C infection. These patients are infected with the Hepatitis C virus (HCV) of genotypes 1-6 and are those that have not developed liver cirrhosis or those who have developed mild cirrhosis. The approval for Mavyret was given to AbbVie Inc.

3 Aug 2017

Sheffield scientists discover that simple arthritis drug could help treat blood cancer sufferers

Blood cancer sufferers could be treated with a simple arthritis drug, scientists at the University of Sheffield have discovered.

3 Aug 2017

U.S. FDA approves updated labeling for pan-genotypic single tablet regimen for HCV/HIV co-infected patients

Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved updated labeling for Epclusa (sofosbuvir 400mg/velpatasvir 100mg), the first all-oral, pan-genotypic, once-daily single tablet regimen (STR) for the treatment of adults with chronic hepatitis C virus (HCV) infection, to include use in patients co-infected with HIV.

1 Aug 2017

Researchers create smart, mechanized undergarment to offload stress on the low back

TV infomercials offer a world of potential solutions for back pain, but most of them have at least one of three problems - they're unproven, unworkable or just plain unattractive.

1 Aug 2017

Inflammatory biomarkers may help diagnose chronic fatigue syndrome

Researchers have discovered inflammation biomarkers that could help scientists to research, diagnose and even treat chronic fatigue syndrome (CFS). Also referred to as myalgic encephomyelitis, CFS is a poorly-understood condition characterized by profound, long-term tiredness.

1 Aug 2017

Resistance training may have protective effect on the brain in multiple sclerosis patients

In the past, multiple sclerosis patients were advised not to exercise for fear of exacerbating the illness. However, it is now known that physical training can relieve many of the symptoms, including the excessive fatigue and mobility impairments that are often seen.

1 Aug 2017

Teens exposed to violence have greater risk for obesity, study suggests

Teens consumed more unhealthy foods and beverages on days they were exposed to violence, and suffered from fatigue due to poor sleep the next day, according to a new study by Duke researchers. Those behaviors, especially increased soda consumption, are important predictors of weight gain.

31 Jul 2017

Researchers create rum flavor lexicon to accurately describe nuances found in different varieties

Aficionados use words like "oaky" to describe some wines, or "hoppy" when talking about certain beers. But for rum—a product with over 1,000 different varieties—putting the words together to describe what imbibers are smelling and tasting is a bit more difficult.

31 Jul 2017

New study examines efficacy of extended-release guanfacine in children with chronic tic disorders

A new study assessed the safety, tolerability, and effectiveness of extended-release guanfacine in children 6-17 years of age who have chronic tic disorders including Tourette's disorder.

26 Jul 2017

Kidenga app tracks mosquito activity and disease symptoms for summer travelers

Just because Zika isn't in the news as much lately, doesn't mean the mosquito-borne infection no longer is a health threat.

26 Jul 2017

Important things that women need to know about heart disease

Did you know that heart disease impacts men and women differently? Research has shown that gender differences exist not only in the way disease affects the heart, but also in the symptoms and the way it is diagnosed.

25 Jul 2017

Physical activity linked to reduced fatigue, better cognitive function in cancer survivors

A new study indicates that cancer patients and survivors have a ready weapon against fatigue and "chemo brain": a brisk walk.

25 Jul 2017

California Valley Fever cases highest on record

The number of Valley Fever cases in California rose to a record level in 2016, with 5,372 reported — a jump of 71 percent from the previous year. Historically, about three-quarters of cases have been in the state's heavily agricultural San Joaquin Valley.

24 Jul 2017

Fatigue News and Research

An exercise pill for heart failure patients

Immunotherapy shows promise in treatment of Type 1 diabetes

Early detection, treatment of frailty may help elderly people live healthier lives

Increase in reported cases of Cyclospora infections compared to last year, CDC reports

Shortage of Hepatitis B vaccine - prioritization of vaccinations announced in UK

FDA approves new treatment for all HCV genotypes 1-6

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

FDA approves new combo drug Mavyret for adults with Hepatitis C infection

Sheffield scientists discover that simple arthritis drug could help treat blood cancer sufferers

U.S. FDA approves updated labeling for pan-genotypic single tablet regimen for HCV/HIV co-infected patients

Researchers create smart, mechanized undergarment to offload stress on the low back

Inflammatory biomarkers may help diagnose chronic fatigue syndrome

Resistance training may have protective effect on the brain in multiple sclerosis patients

Teens exposed to violence have greater risk for obesity, study suggests

Researchers create rum flavor lexicon to accurately describe nuances found in different varieties

New study examines efficacy of extended-release guanfacine in children with chronic tic disorders

Kidenga app tracks mosquito activity and disease symptoms for summer travelers

Important things that women need to know about heart disease

Physical activity linked to reduced fatigue, better cognitive function in cancer survivors

California Valley Fever cases highest on record

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News